Document Detail

Tissue plasminogen activator and plasminogen activator inhibitor 1 in obese and lean patients with polycystic ovary syndrome.
MedLine Citation:
PMID:  20500107     Owner:  NLM     Status:  MEDLINE    
OBJECTIVE: Disturbances in the fibrinolytic system are predictors of future cardiovascular events. The aim of this study was to compare plasminogen activator inhibitor 1 (PAI-1) activity and tissue plasminogen activator (tPA) mass concentration between patients with polycystic ovary syndrome (PCOS) and control subjects.
DESIGN: One hundred thirty-five patients with PCOS (lean and obese) and 81 healthy controls were recruited for the study. Blood samples for PAI-1 activity and tPA mass were collected together with anthropometric measures.
RESULTS: Obese patients with PCOS displayed increased tPA mass concentration in comparison with controls (p <0.05), and this finding was consistent regardless of whether patients displayed signs of hyperandrogenism or not. When hyperandrogenism was introduced as a prerequisite for the PCOS diagnosis, obese patients with PCOS displayed increased PAI-1 activity as well, p <0.05. Lean patients with PCOS did not differ in terms of PAI-1 activity or tPA mass concentration in comparison to controls.
CONCLUSION: Obese women with PCOS have impaired fibrinolysis, in particular if they also display objective biochemical markers of hyperandrogenism.
Asa Lindholm; Marie Bixo; Mats Eliasson; Miriam Hudecova; Ragnheidur Arnadottir; Jan Holte; Inger Sundström Poromaa
Related Documents :
2448897 - Plasminogen abnormalities in patients with argentine hemorrhagic fever.
9873877 - Prednisone and low-dose activated prothrombin complex concentrates for fviii inhibitor ...
14587047 - High-dose intravenous immunoglobulin treatment in two patients with acquired factor v i...
11073857 - Activation of clotting factors xi and ix in patients with acute myocardial infarction.
7977597 - Metipranolol-associated granulomatous iritis.
3477997 - Brain choline acetyltransferase reduction in dominantly inherited olivopontocerebellar ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology     Volume:  26     ISSN:  1473-0766     ISO Abbreviation:  Gynecol. Endocrinol.     Publication Date:  2010 Oct 
Date Detail:
Created Date:  2010-09-13     Completed Date:  2010-12-14     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  8807913     Medline TA:  Gynecol Endocrinol     Country:  England    
Other Details:
Languages:  eng     Pagination:  743-8     Citation Subset:  IM    
Department of Women's and Children's Health, Uppsala University, Uppsala, Sweden.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Case-Control Studies
Hyperandrogenism / blood,  physiopathology
Obesity / blood*,  complications,  physiopathology
Plasminogen Activator Inhibitor 1 / blood*
Polycystic Ovary Syndrome / blood*,  complications,  physiopathology
Regression Analysis
Tissue Plasminogen Activator / blood*
Reg. No./Substance:
0/Plasminogen Activator Inhibitor 1; EC Plasminogen Activator

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Peri- and post-menopausal incidental adnexal masses and the risk of sporadic ovarian malignancy: new...
Next Document:  Further data favouring hormonal dependency of cerebral meningiomas: evidence from a patient treated ...